CMS certification 220036
Boston Medical Center-Brighton
736 Cambridge Street, Nevins Building, Brighton, MA 02135
Boston Medical Center-Brighton has a CMS overall rating of 3 out of 5 stars. 69% of patients who answered CMS's national survey would definitely recommend it, against a US average of 71%. Of the 24 death, complication, infection and readmission measures CMS could compare, it does better than the nation on 2 and worse on 3. Emergency patients spend a median of 2 h 26 min in its emergency department before leaving (US median 2 h 42 min).
Every figure on this page is published by CMS; we arrange and explain it, and score nothing ourselves.
What patients said
Answers from patients who stayed here, collected by CMS in the national HCAHPS survey: 709 completed surveys, 20% response rate, Oct 2024 – Sep 2025.
Emergency department
How long emergency patients spent here and how some time-critical care went, from CMS's timely and effective care measures, Oct 2024 – Sep 2025. CMS classes this emergency department's patient volume as medium; busier departments tend to have longer times, so the national median for departments of the same volume is shown too. These are medians over a year of visits, not a live wait time.
| Measure | This hospital | MA | US |
|---|---|---|---|
| Median time in the emergency department before leaving Lower is better · 352 visits sampled · US median for EDs of the same volume: 2 h 45 min | 2 h 26 min | 3 h 34 min | 2 h 42 min |
| Median time for psychiatric and mental health patients Lower is better · 42 visits sampled | 3 h 50 min | 5 h 38 min | 4 h 17 min |
| Left before being seen Lower is better · 25,208 patients | 1% | 4% | 2% |
| Severe sepsis and septic shock: all recommended care given Higher is better · 42 patients | 40% | 56% | 65% |
How Boston Medical Center-Brighton compares with nearby hospitals
The closest hospitals of the same kind that CMS rates or surveys - the same city first, then the same county and ZIP area. Every figure is CMS's: the overall star rating, the share of patients who would definitely recommend the hospital, the median time emergency patients spent before leaving, and how many death, complication, infection and readmission measures CMS found better or worse than the national rate.
| Hospital | CMS stars | Would recommend | ER median time | Vs the nation |
|---|---|---|---|---|
| Boston Medical Center-BrightonThis hospital | 3/5 | 69% | 2 h 26 min | 2 better 3 worse |
| Brigham and Women Faulkner HospitalSame county · Jamaica Plain | 5/5 | 74% | 4 h 16 min | 7 better |
| VA Boston Healthcare System - Jamaica PlainSame county · Jamaica Plain | 4/5 | 77% | — | 2 better 4 worse |
| New England Baptist HospitalSame county · Boston | 5/5 | 86% | — | 2 better 1 worse |
| Boston Medical CenterSame county · Boston | 3/5 | 73% | 3 h 47 min | 4 better 1 worse |
| Brigham and Women's HospitalSame county · Boston | 5/5 | 81% | 5 h | 8 better 2 worse |
Hospitals differ in size and in how sick their patients are. CMS adjusts its outcome measures for that, but a star or a percentage is a starting point for questions, not a verdict. All hospitals in Brighton.
Deaths
How many patients died within 30 days of admission, adjusted by CMS for how sick they were. Lower is better. Data from Jul 2022 – Jun 2025.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| All patients, hospital-wide 1,413 cases | Too few cases | 3.5% | 3.9% |
| Heart attack 127 cases | Too few cases | 11.5% | 11.9% |
| Heart failure 170 cases | Too few cases | 9.7% | 11.1% |
| Pneumonia 115 cases | Too few cases | 14.2% | 15.2% |
| Stroke 87 cases | Too few cases | 8.9% | 11.9% |
| Heart bypass surgery (CABG) 227 cases | Too few cases | 2.1% | 2.4% |
1 more measure had too few cases here to report.
Complications
How often patients had serious complications, most of them after surgery, adjusted for how sick they were. Lower is better. Data from Jul 2022 – Jun 2024.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| Serious complications, combined measure | No different | 0.79 likely 0.52 – 1.06 | 1 |
| After hip or knee replacement 88 cases | Too few cases | 2.9% | 4.1% |
| Deaths after a serious but treatable surgical complication 96 cases | No different | 192.24 per 1,000 likely 147.05 per 1,000 – 237.42 per 1,000 | 173.3 per 1,000 |
| Pressure ulcers (bed sores) 4,096 cases | No different | 0.46 per 1,000 likely 0 per 1,000 – 1.09 per 1,000 | 0.63 per 1,000 |
| Collapsed lung caused by a procedure 4,688 cases | No different | 0.17 per 1,000 likely 0 per 1,000 – 0.36 per 1,000 | 0.21 per 1,000 |
| Broken bones from falls in the hospital 5,239 cases | No different | 0.25 per 1,000 likely 0.06 per 1,000 – 0.44 per 1,000 | 0.27 per 1,000 |
| Bleeding or hematoma after surgery 1,981 cases | No different | 2.67 per 1,000 likely 1.36 per 1,000 – 3.98 per 1,000 | 2.34 per 1,000 |
| Kidney injury needing dialysis after surgery 983 cases | No different | 1.08 per 1,000 likely 0 per 1,000 – 2.47 per 1,000 | 1.67 per 1,000 |
| Breathing failure after surgery 1,013 cases | No different | 7.14 per 1,000 likely 2.43 per 1,000 – 11.84 per 1,000 | 9.42 per 1,000 |
| Blood clots in the lungs or legs after surgery 2,008 cases | No different | 2.73 per 1,000 likely 0.88 per 1,000 – 4.58 per 1,000 | 3.52 per 1,000 |
| Sepsis after surgery 915 cases | No different | 4.35 per 1,000 likely 1.17 per 1,000 – 7.52 per 1,000 | 5.27 per 1,000 |
| Surgical wound splitting open 370 cases | No different | 1.58 per 1,000 likely 0.13 per 1,000 – 3.02 per 1,000 | 1.77 per 1,000 |
| Accidental cut or tear during abdominal surgery 1,022 cases | No different | 1.04 per 1,000 likely 0.08 per 1,000 – 2 per 1,000 | 1.06 per 1,000 |
Infections caught in the hospital
Standardized infection ratio: 1.0 means as many infections as CMS predicted for a hospital like this one. Lower is better. Data from Oct 2024 – Sep 2025.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| Bloodstream infections from central lines (CLABSI) | No different | 0.52 likely 0.13 – 1.41 | 1 |
| Urinary tract infections from catheters (CAUTI) | No different | 0.46 likely 0.15 – 1.11 | 1 |
| Surgical site infections after colon surgery | No different | 0.79 likely 0.04 – 3.9 | 1 |
| MRSA bloodstream infections | Better | 0 | 1 |
| C. diff intestinal infections | Better | 0.19 likely 0.06 – 0.47 | 1 |
1 more measure had too few cases here to report.
Readmissions and return visits
How often patients had to come back to a hospital after going home. Lower is better. Data from Jul 2023 – Jun 2025.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| Readmitted after a heart attack 236 cases | Too few cases | 15.8% | 14.4% |
| Readmitted after heart failure 242 cases | Too few cases | 20.3% | 21.3% |
| Readmitted after pneumonia 145 cases | Too few cases | 18.1% | 17.3% |
| Readmitted after COPD 36 cases | Too few cases | 20.2% | 20% |
| Readmitted after heart bypass surgery 140 cases | Too few cases | 9.8% | 11% |
| Readmitted after hip or knee replacement 66 cases | Too few cases | 6.4% | 5.8% |
| Days back in hospital after a heart attack 253 cases | Too few cases | 30.2 days per 100 | — |
| Days back in hospital after heart failure 239 cases | Too few cases | -2.1 days per 100 | — |
| Days back in hospital after pneumonia 130 cases | Too few cases | 34.4 days per 100 | — |
| Unplanned visits after an outpatient colonoscopy 651 cases | No different | 12.8 per 1,000 likely 9.6 per 1,000 – 17 per 1,000 | 13 per 1,000 |
| Unplanned visits after outpatient surgery 193 cases | No different | 0.9 likely 0.7 – 1.3 | — |
3 more measures had too few cases here to report.
Clinicians registered at this address
580 clinicians give this hospital's street address as their practice location in NPPES, the federal provider registry, plus 114 residents and trainees. The same address can take in offices and clinics in the building, and a listing does not prove admitting privileges or current employment.
| Specialty | Clinicians |
|---|---|
| Internal Medicine | 112 |
| Anesthesiology | 80 |
| Psychiatry | 40 |
| Surgery | 39 |
| Physician Assistant | 32 |
| Diagnostic Radiology | 16 |
| Cardiovascular Disease | 15 |
| Clinical | 14 |
| Otolaryngology | 12 |
| Neurology | 11 |
| Physical Therapist | 11 |
| Anatomic Pathology & Clinical Pathology | 10 |
First 12 alphabetically
Money from drug and device companies
Drug and device makers have to report what they pay teaching hospitals to CMS's Open Payments program. At many teaching hospitals most of it is research funding, or royalties for inventions the hospital licensed to a company. A payment on its own does not show a conflict of interest.
- 2019 $422,614
- 2020 $187,128
- 2021 $198,195
- 2022 $294,020
- 2023 $179,412
- 2024 $2.8M
- 2025 $874,711
What the 2025 general payments were for
| Type of payment | Amount | Payments |
|---|---|---|
| Debt forgiveness | $797,757 | 12 |
Largest paying companies, 2025
| Company | Amount | Payments |
|---|---|---|
| Edwards Lifesciences Corporation | $317,750 | 1 |
| Zimmer Biomet Holdings, Inc. | $268,631 | 1 |
| Change Healthcare Technologies, LLC | $105,417 | 1 |
| Penumbra, Inc. | $93,802 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $69,754 | 10 |
| Immucor, Inc. | $6,122 | 1 |
| Baxter Healthcare | $5,472 | 6 |
| E.R. Squibb & Sons, L.L.C. | $3,333 | 1 |
Largest research studies funded here, 2025
| Study | Amount |
|---|---|
| An open-label extension trial of the long-term safety and efficacy of BI 1015550 taken orally in patients with idiopathic pulmonary fibrosis (IPF) an… Boehringer Ingelheim Pharmaceuticals, Inc. | $53,057 |
| A double blind, randomized, placebo-controlled trial evaluating the efficacy and safety of BI 1015550 over at least 52 weeks in patients with Progres… Boehringer Ingelheim Pharmaceuticals, Inc. | $13,999 |
| A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 2 Study of the Efficacy and the Safety and Tolerability of BMS-986278 in Participa… E.R. Squibb & Sons, L.L.C. | $3,333 |
| A double blind, randomized, placebo-controlled trial evaluating the efficacy and safety of BI 1015550 over at least 52 weeks in patients with Idiopat… Boehringer Ingelheim Pharmaceuticals, Inc. | $2,698 |
| Phase 3 Multi Center Randomized Double Blind Placebo Controlled Study to Evaluate the Efficacy Safety Pharmacokinetics and Pharmacodynamics of Nipoca… Janssen Research & Development, LLC | $1,750 |
| An Open-Label Extension of Studies M15-736 and M20-339 to Evaluate the Safety and Tolerability of 24-Hour Daily Exposure of ABBV-951 in Subjects With… ABBVIE INC. · NCT04750226 | $1,657 |
| NCT04227899--LIFE-BTK Randomized Controlled Trial Abbott Laboratories | $460 |
Amounts are as the paying companies reported them to CMS; Open Payments data retrieved 13 Sep 2026. Full record on CMS Open Payments.
How to read this page
- Everything here is published by CMS on Care Compare. We arrange it and explain it; the star ratings and the better / worse verdicts are CMS's, not ours.
- “No different” is the most common result on most measures at most hospitals. CMS only calls a result better or worse when the difference from the national rate is statistically clear.
- Death, complication and readmission rates are adjusted by CMS for how sick patients were, so hospitals that treat sicker patients can be compared fairly.
- Infection results are ratios: 1.0 means as many infections as CMS predicted for a hospital like this one, below 1.0 is fewer.
- These are hospital-wide results. They do not rate an individual doctor, nurse or department, and they are not medical advice.
CMS Care Compare data retrieved 4 Oct 2026, refreshed weekly. Where this data comes from and how we handle it · Report an error
Common questions about Boston Medical Center-Brighton
Is Boston Medical Center-Brighton a good hospital?
Boston Medical Center-Brighton has a CMS overall rating of 3 out of 5 stars. Of the 24 death, complication, infection and readmission measures CMS could compare, it does better than the nation on 2 and worse on 3. These are hospital-wide results published by CMS; they do not rate individual doctors or departments.
Would patients recommend Boston Medical Center-Brighton?
69% of patients who answered CMS's national survey would definitely recommend it, against a US average of 71%. The figure comes from 709 completed HCAHPS surveys.
How long is the wait in the Boston Medical Center-Brighton emergency room?
Emergency patients spend a median of 2 h 26 min in its emergency department before leaving (US median 2 h 42 min). Among US emergency departments with medium patient volume, like this one, the median is 2 h 45 min. 1% of emergency patients left before being seen (US 2%). These are medians over a year of visits, not a live wait time.
Does Boston Medical Center-Brighton receive money from drug and device companies?
Drug and device makers reported $874,711 in payments to Boston Medical Center-Brighton for 2025, under the federal Open Payments program. A payment on its own does not show a conflict of interest.